We serve Chemical Name:Methyl isonicotinate CAS:2459-09-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Methyl isonicotinate
CAS.NO:2459-09-8
Synonyms:Methyl Pyridine-4-carboxylate;pyridine-4-carboxylic acid methyl ester;Isonicotinic Acid Methyl Ester;Isonicotinic acid, methyl ester (8CI);4-Pyridinecarboxylic acid,methyl ester;4-Methoxycarbonylpyridine;Methyl isonicotinate;4-Pyridinecarboxylic acid, methyl ester;4-carbomethoxypyridine;Methyl 4-pyridinecarboxylate;EINECS 219-546-8;MFCD00006427;Isonicotinic acid, methyl ester
Molecular Formula:C7H7NO2
Molecular Weight:137.136
HS Code:2933399090
Physical and Chemical Properties:
Melting point:8-8.5 °C(lit.)
Boiling point:205.1±13.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.511
PSA:39.19000
Exact Mass:137.047684
LogP:0.88
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NA 1993 / PGIII
Packing Group:
Contact us for information like Methyl Pyridine-4-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Isonicotinic acid, methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl Pyridine-4-carboxylate Use and application,EINECS 219-546-8 technical grade,usp/ep/jp grade.
Related News: The Company��s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA. Methyl isonicotinate manufacturer First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory. Methyl isonicotinate supplier The Company��s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA. Methyl isonicotinate vendor First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory. Methyl isonicotinate factory He was the partner of a 38-year-old Chinese woman who was travelling with him. She was the first confirmed case reported in the Philippines.